A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer

NCT04623333 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent or Metastatic Cervical Cancer

Interventions

DRUG: TQB2450

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.